Cargando…
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
Taxol is a widely used chemotherapy drug used clinically for ovarian cancer, although the response to Taxol among individuals varies due to the heterogeneity among ovarian cancer patients. In this work, we analyzed differences in the prognostic effect of gene expression and Taxol usage in the Cancer...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832203/ https://www.ncbi.nlm.nih.gov/pubmed/29494610 http://dx.doi.org/10.1371/journal.pone.0192812 |